‘Imminent’ Generic Approvals Expected To Help US FDA Meet On-Time Review Metric Retroactively

 
• By Derrick Gingery
Generic drug pills
The falling on-time action rate for generic drug applications could be a concern for sponsors. • Source: Alamy

More from Review Pathways

More from Pathways & Standards